Page 1 | Search Results | Blood | American Society of Hematology

1-11 of 11

Sort by

Sort Order Select

Journal Articles

Germline Variants Associated with Cancer Predisposition and Bone Marrow Failure Are Common in KMT2A- r Infant Acute Lymphoblastic Leukemia Patients

Sarah Mc Dermott, DO, Midhat S. Farooqi, MD PhD, Azhar Saeed, MD, Byunggil Yoo, MS, Emily Farrow, PhD CGC, Neil Miller, Patrick A. Brown, MD, Erin Guest, MD

Blood (2020) 136 (Supplement 1): 41.

https://doi.org/10.1182/blood-2020-139564

Published: 2020

Journal Articles

Single Cell Sequencing Reveals Heterogeneity of Gene Expression in KMT2A Rearranged Infant ALL at Relapse Compared to Diagnosis

Erin Guest, MD, Byunggil Yoo, MS, Rumen Kostadinov, PhD, Midhat S. Farooqi, MD PhD, Emily Farrow, PhD CGC, Margaret Gibson, Neil Miller, Karina Shah, Tomi Pastinen, MD PhD, Patrick A. Brown, MD

Blood (2019) 134 (Supplement_1): 2756.

https://doi.org/10.1182/blood-2019-131999

Published: 2019

Journal Articles

Genomic Analysis and Pathway Characterization of Genes with Somatic Variants in Infant Acute Lymphoblastic Leukemia

Jillian Fry, Midhat S. Farooqi, MD PhD, Byunggil Yoo, MS, Rumen Kostadinov, PhD, Emily Farrow, PhD CGC, Shannon Kelley, MS, Margaret Gibson, Neil Miller, Jeffrey Johnston, Patrick Brown, MD, Erin Guest, MD

Blood (2017) 130 (Supplement 1): 3970.

https://doi.org/10.1182/blood.V130.Suppl_1.3970.3970

Published: 2017

Journal Articles

Landscape of Somatic Mutations and Gene Expression Changes in Relapsed Infant MLL-Rearranged Acute Lymphoblastic Leukemia

Rumen Kostadinov, PhD, Midhat Farooqi, MD PhD, Byunggil Yoo, MS, Emily Farrow, PhD CGC, Shannon Kelley, Margaret Gibson, Neil Miller, Erin M. Guest, MD, Patrick Brown, MD

Blood (2016) 128 (22): 1735.

https://doi.org/10.1182/blood.V128.22.1735.1735

Published: 2016

Journal Articles

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

Blood (2016) 128 (4): 497–503.

https://doi.org/10.1182/blood-2016-02-700872

Published: 2016

Journal Articles

An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Meletios A. Dimopoulos, Antonio Palumbo, Paolo Corradini, Michele Cavo, Michel Delforge, Katja C. Weisel, Enrique M. Ocio, MD PhD, Francesco Di Raimondo, Markus Hansson, Mathew Simcock, Neil Miller, Ana Slaughter, Teresa Peluso, Lars Sternas, Mohamed H Zaki, Philippe Moreau

Blood (2015) 126 (23): 4225.

https://doi.org/10.1182/blood.V126.23.4225.4225

Published: 2015

Journal Articles

Analysis of Patient (Pt) Outcomes By Prior Treatment and Depth of Response in Stratus (MM-010), a Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Blood (2015) 126 (23): 1834.

https://doi.org/10.1182/blood.V126.23.1834.1834

Published: 2015

Journal Articles

Use of Dried Blood Spots for High through-Put, Rapid Turnaround Mutational Analysis in Patients with Hemophilia

Shannon L. Carpenter, MD MS, Emily Farrow, PhD, Lauren Amos, MD, Neil Miller, BA, Margaret Gibson, BA, Sara Streeter, Byunggil Yoo, PhD, Suzanne Herd, Sarah Soden, Stephen Kingsmore, M.B., Ch.B., B.A.O., D.Sc.

Blood (2014) 124 (21): 5034.

https://doi.org/10.1182/blood.V124.21.5034.5034

Published: 2014

Journal Articles

Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010)

Katja Weisel, MD, Meletios A. Dimopoulos, MD, Michele Cavo, MD, Enrique M. Ocio, MD PhD, Antonio Palumbo, MD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Harmut Goldschmidt, MD, Concetta Conticello, MD, Angelo Vacca, MD PhD, Markus Hansson, MD PhD, Neil Miller, CRS, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD, Philippe Moreau, MD

Blood (2014) 124 (21): 4755.

https://doi.org/10.1182/blood.V124.21.4755.4755

Published: 2014

Journal Articles

Safety and Efficacy in the Stratus (MM-010) Trial, a Single-Arm Phase 3b Study Evaluating Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma

Meletios A. Dimopoulos, MD, Antonio Palumbo, MD, Katja Weisel, MD, Enrique M. Ocio, MD PhD, Michele Cavo, MD, Paolo Corradini, MD PhD, Michel Delforge, MD PhF, Albert Oriol, MD, Hartmut Goldschmidt, MD, María Jesús Blanchard, MD, Chantal Doyen, MD, Gareth J Morgan, MD PhD, Mathew Simcock, MSc, Neil Miller, CRS, Ana Slaughter, PhD, Teresa Peluso, MBBS, Lars Sternas, MD, Mohamed H. Zaki, MD PhD, Philippe Moreau, MD

Blood (2014) 124 (21): 80.

https://doi.org/10.1182/blood.V124.21.80.80

Published: 2014

Journal Articles

An Unusual Presentation of Congenital Dyserythropoietic Anemia Type II (CDAII) Associated with Severe Anemia in a Patient with a Novel Mutation of the SEC23B Gene

Melanie A Villanueva, DO, Carol J Saunders, Ph.D, David Zwick, MD, Laurie Smith, MD, PhD, Darrell Dinwiddie, PhD, Emily Farrow, PhD, Neil Miller, BA, Stephen Kingsmore, M.B., Ch.B., B.A.O., D.Sc., Keith J. August, M.D., M.Sc.

Blood (2012) 120 (21): 990.

https://doi.org/10.1182/blood.V120.21.990.990

Published: 2012

NARROW

Germline Variants Associated with Cancer Predisposition and Bone Marrow Failure Are Common in KMT2A- r Infant Acute Lymphoblastic Leukemia Patients

Single Cell Sequencing Reveals Heterogeneity of Gene Expression in KMT2A Rearranged Infant ALL at Relapse Compared to Diagnosis

Genomic Analysis and Pathway Characterization of Genes with Somatic Variants in Infant Acute Lymphoblastic Leukemia

Landscape of Somatic Mutations and Gene Expression Changes in Relapsed Infant MLL-Rearranged Acute Lymphoblastic Leukemia

Safety and efficacy of pomalidomide plus low-dose dexamethasone in STRATUS (MM-010): a phase 3b study in refractory multiple myeloma

An Updated Analysis of the Stratus Trial (MM-010): Safety and Efficacy of Pomalidomide Plus Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Analysis of Patient (Pt) Outcomes By Prior Treatment and Depth of Response in Stratus (MM-010), a Phase 3b Study of Pomalidomide + Low-Dose Dexamethasone (POM + LoDEX) in Patients (Pts) with Relapsed/Refractory Multiple Myeloma (RRMM)

Use of Dried Blood Spots for High through-Put, Rapid Turnaround Mutational Analysis in Patients with Hemophilia

Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma and Renal Impairment: Analysis of Patients from the Phase 3b Stratus Trial (MM-010)

Safety and Efficacy in the Stratus (MM-010) Trial, a Single-Arm Phase 3b Study Evaluating Pomalidomide + Low-Dose Dexamethasone in Patients with Refractory or Relapsed and Refractory Multiple Myeloma

An Unusual Presentation of Congenital Dyserythropoietic Anemia Type II (CDAII) Associated with Severe Anemia in a Patient with a Novel Mutation of the SEC23B Gene

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only